Medincell SA

11/01/2021 | Press release | Distributed by Public on 11/01/2021 00:52

Phase 3 data of mdc-IRM, first product based on MedinCell’s technology, shows significant improvements in patients with schizophrenia: Prolonged time to impending relapse /[...]